Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit

Journal of Immunology

Volumn 167, Issue 4, 2001, Pages 2379-2387

  Costa, G L ^a   Sandora, M R ^a   Nakajima, N ^a   Nguyen, E V ^a   Taylor Edwards, C ^a   Slavin, A J ^a   Contag, C H ^a   Fathman, C G ^a   Benson, J M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MYELIN BASIC PROTEIN; VIRUS VECTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE;

EID: 0035881597     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.4.2379     Document Type: Article

References (61)

1. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
2. Insulin-dependent diabetes mellitus
3. Cytokines in autoimmune disorders
4. Suppression of collagen-induced arthritis by continuous administration of IL-4
5. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice
6. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis
7. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice
8. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats
9. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies
10. Safety evaluation of recombinant human interleukin-4. II. Clinical studies
11. Cloning and expression of murine IFN β and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis
12. Intra-articular IL-4 gene therapy in arthritis: Anti-inflammatory effect and enhanced Th2 activity
13. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
14. Tighter watch urged on adenoviral vectors ... with proposal to report all "adverse events"
15. NIH tightens up monitoring of gene-therapy mishaps
16. Human gene therapy: Science under fire
17. Transgenic monkeys produced by retroviral gene transfer into mature oocytes
18. Gene therapy of human severe combined immunodeficiency (SC1D)-X1 disease
19. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease
20. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis
21. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis
22. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells
23. Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-β1
24. + T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses
25. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE)
26. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis
27. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
28. Interferon-γ confers resistance to experimental allergic encephalomyelitis
29. α-Interferon inhibits the development of diabetes in NOD mice
30. Heterogeneous effects of IL-2 on collagen-induced arthritis
31. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
32. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
33. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-γ receptor-deficient mice
34. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice
35. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease
36. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
37. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity
38. Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist
39. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
40. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
41. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis
42. Dual-function reporter protein for analysis of gene expression in living cells
43. Production of high-titer helper-free retroviruses by transient transfection
44. Two better cell lines for making hybridomas expressing specific T cell receptors
45. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
46. Visualizing the kinetics of tumor-cell clearance in living animals
47. Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer
48. Structural basis of spectral shifts in the yellow-emission variants of green fluorescent protein
49. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis
50. + T cells
51. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
52. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells
53. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
54. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4
55. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
56. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
57. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis
58. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen
59. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis
60. Suppression of cyclophosphamide-induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2
61. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes